Gilead Sciences M&A Summary
Gilead Sciences has acquired 24 companies, including 8 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 3 assets.
Gilead Sciences’ largest acquisition to date was in 2020, when it acquired Immunomedics for $21.0B. It’s largest disclosed sale occurred in 2001, when it sold Gilead Oncology Business to OSI Pharmaceuticals for $200M. Gilead Sciences has acquired in 7 different US states, and 6 countries. The Company’s most targeted sectors include life science (96%) and chemicals (5%).
M&A Summary
-
M&A Total Activity27
- M&A Buy Activity24
- M&A Sell Activity3
- Total Sectors Invested 2
- Total Countries Invested 6
- M&A Buy/Sell Connections 7
Unlimited Searches
